USMLE Dermatology: Melanoma ABCDE Criteria, Breslow Thickness, Risk Factors

What This Is and Why It Matters for USMLE

Melanoma is a high-yield topic for Step 1, Step 2 CK, and Step 3. It is a common malignancy with a high mortality rate if not diagnosed early. The ABCDE criteria, Breslow thickness, and risk factors are key concepts to understand for the USMLE.

High-Yield Facts (What You Must Memorize)

• Pathophysiology (Step 1): Melanoma arises from melanocytes, which are cells that produce melanin. Mutations in genes such as BRAF and NRAS lead to uncontrolled cell growth.
• Classic presentation and physical exam findings (Step 2 CK): The ABCDE criteria include:
  • Asymmetry
  • Border irregularity
  • Color variation
  • Diameter > 6mm
  • Evolving
• Diagnostic approach (labs, imaging): Biopsy is the gold standard for diagnosis. Imaging studies such as ultrasound and MRI may be used to assess for metastasis.
• First-line treatment and management (Step 2 CK, Step 3): Surgical excision is the primary treatment for localized melanoma. Adjuvant therapy with interferon-alpha may be used for high-risk patients.
• Red flags, complications, and follow-up: Metastatic disease is a red flag, and patients should be monitored for symptoms such as weight loss and fatigue.

Clinical Pearls & Buzzwords

• Breslow thickness: A measure of tumor depth, which is a prognostic factor for melanoma.
• Clark level: A measure of tumor invasion, which is also a prognostic factor.
• Sentinel lymph node biopsy: A procedure to assess for lymph node metastasis.
• Melanoma-specific mortality: The risk of death from melanoma is higher in patients with thicker tumors and those with lymph node metastasis.

Step-by-Step Clinical Reasoning

1. Identify the syndrome or presentation: A patient presents with a new skin lesion that is asymmetrical and has an irregular border.
2. Generate a differential (most likely and must-not-miss): Melanoma, basal cell carcinoma, squamous cell carcinoma.
3. Order appropriate initial tests: Biopsy of the skin lesion.
4. Interpret results: The biopsy confirms melanoma.
5. Initiate treatment and monitoring: Surgical excision of the tumor and monitoring for metastasis.

Missing a life-threatening complication: Patients with melanoma are at risk for metastasis to the brain and lungs.

Common Mistakes & Exam Traps

• The mistake: Failing to recognize the importance of Breslow thickness in determining prognosis.
• Why it happens: Rushing through the exam and not taking the time to read the question carefully.
• How to avoid it: Take your time and read the question carefully, and make sure to understand the importance of Breslow thickness.

• Exam board insight: The examiners will penalize you for not recognizing the importance of Breslow thickness.

• The mistake: Failing to order a sentinel lymph node biopsy in patients with high-risk melanoma.

• Why it happens: Not understanding the indications for sentinel lymph node biopsy.
• How to avoid it: Make sure to understand the indications for sentinel lymph node biopsy and order it in patients with high-risk melanoma.
• Exam board insight: The examiners will penalize you for not ordering a sentinel lymph node biopsy in patients with high-risk melanoma.

How It’s Tested on USMLE

• Step 1: Basic science vignette (e.g., molecular mechanism, pathology slide, pharmacology).
• Step 2 CK: Clinical vignette (e.g., "A 45-year-old with a new skin lesion...").
• Step 3: Similar to Step 2 CK, plus prognosis, risk factors, and occasionally CCS management.

CCS (Step 3) Relevance (If Applicable)

• Initial orders: Order a biopsy of the skin lesion to confirm the diagnosis.
• Monitoring and follow-up: Monitor the patient for symptoms of metastasis and order imaging studies as needed.
• Common mistakes: Failing to order a sentinel lymph node biopsy in patients with high-risk melanoma.

Practice Questions (3-5 single-best-answer)

Question 1: A 45-year-old patient presents with a new skin lesion that is asymmetrical and has an irregular border. Which of the following is the most likely diagnosis?

Options: A) Basal cell carcinoma, B) Squamous cell carcinoma, C) Melanoma, D) Seborrheic keratosis

Answer: C) Melanoma

Explanation: The ABCDE criteria are a useful tool for identifying melanoma. This patient's lesion is asymmetrical and has an irregular border, which are two of the criteria for melanoma.

Question 2: A patient is diagnosed with melanoma and has a Breslow thickness of 2mm. What is the prognosis for this patient?

Options: A) Good, B) Fair, C) Poor, D) Cannot be determined

Answer: D) Cannot be determined

Explanation: The prognosis for melanoma depends on several factors, including Breslow thickness, Clark level, and lymph node status. A Breslow thickness of 2mm is not sufficient to determine the prognosis.

Question 3: A patient is diagnosed with melanoma and has lymph node metastasis. What is the next step in management?

Options: A) Surgical excision of the tumor, B) Adjuvant therapy with interferon-alpha, C) Sentinel lymph node biopsy, D) Chemotherapy

Answer: C) Sentinel lymph node biopsy

Explanation: The next step in management for a patient with lymph node metastasis is to perform a sentinel lymph node biopsy to assess for further metastasis.

Quick Reference Card (60-Second Summary)

• ABCDE criteria: Asymmetry, Border irregularity, Color variation, Diameter > 6mm, Evolving
• Breslow thickness: A measure of tumor depth, which is a prognostic factor for melanoma.
• Sentinel lymph node biopsy: A procedure to assess for lymph node metastasis.
• Melanoma-specific mortality: The risk of death from melanoma is higher in patients with thicker tumors and those with lymph node metastasis.

If You Get Stuck on Test Day

• Eliminate obviously wrong answers: If you are unsure of the answer, eliminate any options that are clearly incorrect.
• Use the "next best step" hierarchy: Start with the least invasive option and work your way up to the most invasive option.
• For Step 3 CCS: Order basic labs and vitals, and consider ordering imaging studies as needed.

Related USMLE Topics

• Skin cancer: Melanoma is a type of skin cancer that arises from melanocytes.
• Cancer staging: Melanoma is staged using the TNM system, which takes into account the size and extent of the tumor, as well as the presence of lymph node metastasis.
• Immunotherapy: Immunotherapy is a treatment option for melanoma that involves using medications to stimulate the immune system to attack cancer cells.